| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eliem Therapeutics, Inc. | EVP and General Counsel | Stock Option (Right to Buy) | 95K | Oct 31, 2022 | Direct | ||
| Harpoon Therapeutics, Inc. | Chief Legal Officer | Employee Stock Option (Right to Buy) | 0 | Mar 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HARP | Harpoon Therapeutics, Inc. | Mar 11, 2024 | 1 | $0 | 4 | Mar 11, 2024 | Chief Legal Officer |
| HARP | Harpoon Therapeutics, Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Chief Legal Officer |
| HARP | Harpoon Therapeutics, Inc. | Dec 21, 2023 | 0 | $0 | 3 | Dec 26, 2023 | Chief Legal Officer |
| ELYM | Eliem Therapeutics, Inc. | Oct 31, 2022 | 1 | $0 | 4 | Nov 2, 2022 | EVP and General Counsel |
| ELYM | Eliem Therapeutics, Inc. | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | EVP and General Counsel |
| ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | EVP and General Counsel |